POLD1 is highly expressed in various cancers, including bladder, breast, endometrial, colorectal, lung, and hepatocellular carcinoma, as evidenced by both clinical studies and TCGA database analyses (16, 21–25) However, its expression patterns yield paradoxical clinical outcomes depending on tumor context. Here, POLD1 is linked to hepatocellular carcinoma.